Molecule Property Analyses of Active Compounds for Mycobacterium tuberculosis

Area of Science:

• Medicinal Chemistry
• Drug Discovery
• Cheminformatics

Background:

• Tuberculosis (TB) remains a major global health threat, causing 1.7 million deaths annually.
• The rise of multidrug-resistant tuberculosis (MDR-TB) complicates treatment and necessitates urgent development of new therapies.
• Despite significant research, the pipeline for novel antitubercular drugs faces challenges due to waning resources and interest.

Purpose of the Study:

• To analyze trends in antitubercular compound discovery over the past decade.
• To identify limitations in current drug discovery approaches for tuberculosis.
• To propose strategies for generating novel and improved antitubercular leads.

Main Methods:

• Cheminformatics analysis of over 100 active antitubercular leads.
• Evaluation of chemical diversity within identified compound classes.
• Comparison of current compound properties against historical tuberculosis drug discovery space.

Main Results:

• Thousands of active compounds generated over the last decade originate from a limited number of chemical classes and natural product sources.
• Existing antitubercular drug discovery efforts frequently rediscover compounds similar to previously identified ones.
• The majority of identified leads fall within a historically explored chemical and property space for Mycobacterium tuberculosis (Mtb).

Conclusions:

• Current approaches to antitubercular drug discovery are not yielding sufficient chemical diversity.
• To discover novel and improved antitubercular leads, there is a critical need to expand the chemical space and diversity of libraries being tested.
• Future efforts must move beyond the historic Mtb property space to overcome limitations in drug discovery.